Stock listing

Xbrane Biopharma Ab

Selected listing: XBRANE · OMXSTO · SEK · SE

Xbrane Biopharma Ab (Stockholm:XBRANE), Health Technology. Latest release Jul 17, 2026: Xbrane Biopharma : releases Interim Report for January-June 2026.

XBRANE:OMXSTOSEKSEUpdated October 3, 2026

Ticker: Stockholm:XBRANE
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Stockholm
Currency: SEK

About Xbrane Biopharma Ab

Xbrane Biopharma AB is a public company traded under the ticker XBRANE on the Swedish market. Xbrane focuses on developing biopharmaceutical products, leveraging its expertise in biotechnology.

Latest news from Xbrane Biopharma Ab

Xbrane Biopharma : releases Interim Report for January-June 2026

July 17, 2026

Xbrane Biopharma AB and JOINN Biologics US Inc. Enter Strategic Partnership to Develop Xdarzane – Xbrane´s Biosimilar Candidate to Darzalex® (Daratumumab)

June 11, 2026

Xbrane Biopharma AB (publ) (“Xbrane” or “the Company”) (Nasdaq Stockholm: XBRANE) receives FDA BsUFA date of October 29, 2026 for its investigational biosimilar candidate to LUCENTIS® (ranibizumab)

June 3, 2026

Xbrane and its partner Intas agree on revised financing arrangement for Xbrane’s Xdivane development activities

May 5, 2026

XBRANE SUBMITS RANIBIZUMAB BIOSIMILAR CANDIDATE TO FDA

April 30, 2026

All Xbrane Biopharma Ab news →

Events

Replays

Xbrane Biopharma AB (publ) (XBRANE) Q2 2026 Earnings Call
Fri, Jul 17, 2026 · 03:00 AM ET
Watch
Xbrane Biopharma AB (publ) (XBRANE) Q1 2026 Earnings Call
Tue, May 05, 2026 · 03:00 AM ET
Watch
Xbrane Biopharma AB (publ) (XBRANE) Q4 2025 Earnings Call
Fri, Feb 20, 2026 · 07:00 AM ET
Watch

Research Xbrane Biopharma Ab

Xbrane Biopharma Ab company profile

View the public company page for Xbrane Biopharma Ab on 6ix.

Xbrane Biopharma Ab news

Read company news and market updates connected to Xbrane Biopharma Ab.

Xbrane Biopharma Ab investor events

Find investor webinars, events, and replay context for Xbrane Biopharma Ab.